Evidence map›Paper›PMID 27595231›Full record

ArticleNature immunology2016

Infection-specific phosphorylation of glutamyl-prolyl tRNA synthetase induces antiviral immunity.

Eun-Young Lee, Hyun-Cheol Lee, Hyun-Kwan Kim, Song Yee Jang, Seong-Jun Park, Yong-Hoon Kim, Jong Hwan Kim, Jungwon Hwang, Jae-Hoon Kim, Tae-Hwan Kim and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. PCBP2 in gastrointestinal cancers: fundamental mechanism and clinical potential.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  7. Human long noncoding RNAJournal of virology · 2025
    Article
  8. Article
  9. AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Human long noncoding RNA,bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 3 countries.

Eun-Young LeeInfection and Immunity Research Laboratory, Microbiomics and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Hyun-Cheol LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, Korea.
Hyun-Kwan KimInfection and Immunity Research Laboratory, Microbiomics and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Song Yee JangInfection and Immunity Research Laboratory, Microbiomics and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Seong-Jun ParkCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea.
Yong-Hoon KimLaboratory Animal Resource Center, KRIBB, University of Science and Technology (UST), Daejeon, Korea.
Jong Hwan KimPersonalized Genomic Medicine Research Center, KRIBB, Daejeon, Korea.
Jungwon HwangInfection and Immunity Research Laboratory, Microbiomics and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Jae-Hoon KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, Korea.
Tae-Hwan KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, Korea.
Abul ArifDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Seon-Young KimPersonalized Genomic Medicine Research Center, KRIBB, Daejeon, Korea.ORCID http://orcid.org/0000-0002-1030-7730
Young-Ki ChoiCollege of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea.
Cheolju LeeCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea.
Chul-Ho LeeLaboratory Animal Resource Center, KRIBB, University of Science and Technology (UST), Daejeon, Korea.
Jae U JungDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Paul L FoxDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sunghoon KimMedicinal Bioconvergence Research Center, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
Jong-Soo LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, Korea.
Myung Hee KimInfection and Immunity Research Laboratory, Microbiomics and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Chungnam National University · KRKorea Research Institute of Bioscience and Biotechnology · KRKorea Institute of Science and Technology · KRCleveland Clinic Lerner College of Medicine · USBiocon (Switzerland) · CHChungbuk National University · KRSeoul National University · KRUniversity of Southern California · US

Funding

Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Molecular Basis of KSHV PathogenesisR01CA082057 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 1999 to 2016
$5.1M
TRIM9-mediated anti-viral immune pathwayR01AI116585 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2015 to 2019
$2.3M
NCI NIH HHS R01 CA082057NHLBI NIH HHS P01 HL029582NIAID NIH HHS R01 AI116585
6 · The paper itself

Abstract

The mammalian cytoplasmic multi-tRNA synthetase complex (MSC) is a depot system that regulates non-translational cellular functions. Here we found that the MSC component glutamyl-prolyl-tRNA synthetase (EPRS) switched its function following viral infection and exhibited potent antiviral activity. Infection-specific phosphorylation of EPRS at Ser990 induced its dissociation from the MSC, after which it was guided to the antiviral signaling pathway, where it interacted with PCBP2, a negative regulator of mitochondrial antiviral signaling protein (MAVS) that is critical for antiviral immunity. This interaction blocked PCBP2-mediated ubiquitination of MAVS and ultimately suppressed viral replication. EPRS-haploid (Eprs

Indexed as

Amino Acyl-tRNA SynthetasesAnimalsDisease Models, AnimalDisease ResistanceHost-Pathogen InteractionsImmunity, InnateMiceMice, KnockoutPeptidesPhosphorylationProtein BindingRNA-Binding ProteinsRNA VirusesRNA Virus InfectionsSignal TransductionUbiquitinationAmino Acyl-tRNA SynthetasesPCBP2 protein, humanPeptidesprolyl T RNA synthetaseRNA-Binding Proteins

Identifiers

PMID27595231
PMCPMC5173487
OpenAlexW2508327349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.